chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: stomach cramps; diarrhea; lower back pain; constant nausea; lymph node under left armpit swollen; chills; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach cramps), DIARRHOEA (diarrhea), BACK PAIN (lower back pain), NAUSEA (constant nausea) and LYMPHADENOPATHY (lymph node under left armpit swollen) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach cramps), DIARRHOEA (diarrhea), BACK PAIN (lower back pain), NAUSEA (constant nausea), LYMPHADENOPATHY (lymph node under left armpit swollen), CHILLS (chills) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (stomach cramps), DIARRHOEA (diarrhea), BACK PAIN (lower back pain), NAUSEA (constant nausea), LYMPHADENOPATHY (lymph node under left armpit swollen), CHILLS (chills) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Dizziness, Headache, Injection site erythema
Clinical narrative: confusion; extreme weakness; Sore arm; unable to put words together; dizziness; headache; injection site redness; fever; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confusion), ASTHENIA (extreme weakness), PAIN IN EXTREMITY (Sore arm), SPEECH DISORDER (unable to put words together) and DIZZINESS (dizziness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced CONFUSIONAL STATE (confusion), ASTHENIA (extreme weakness), PAIN IN EXTREMITY (Sore arm), SPEECH DISORDER (unable to put words together), DIZZINESS (dizziness), HEADACHE (headache), INJECTION SITE ERYTHEMA (injection site redness) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CONFUSIONAL STATE (confusion), ASTHENIA (extreme weakness), PAIN IN EXTREMITY (Sore arm), SPEECH DISORDER (unable to put words together), DIZZINESS (dizziness), HEADACHE (headache), INJECTION SITE ERYTHEMA (injection site redness) and PYREXIA (fever) outcome was unknown.            concomitant medications were not reported.  Patient gave consent to safety for Follow-up.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Speech disorder
Clinical narrative: confusion; extreme weakness; Sore arm; unable to put words together; dizziness; headache; injection site redness; fever; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confusion), ASTHENIA (extreme weakness), PAIN IN EXTREMITY (Sore arm), SPEECH DISORDER (unable to put words together) and DIZZINESS (dizziness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced CONFUSIONAL STATE (confusion), ASTHENIA (extreme weakness), PAIN IN EXTREMITY (Sore arm), SPEECH DISORDER (unable to put words together), DIZZINESS (dizziness), HEADACHE (headache), INJECTION SITE ERYTHEMA (injection site redness) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CONFUSIONAL STATE (confusion), ASTHENIA (extreme weakness), PAIN IN EXTREMITY (Sore arm), SPEECH DISORDER (unable to put words together), DIZZINESS (dizziness), HEADACHE (headache), INJECTION SITE ERYTHEMA (injection site redness) and PYREXIA (fever) outcome was unknown.            concomitant medications were not reported.  Patient gave consent to safety for Follow-up.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; Mild soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Mild soreness of arm) and PAIN IN EXTREMITY (Pain in arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Mild soreness of arm). On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain in arm, at a dose of 1 dosage form and NAPROXEN SODIUM (ALEVE) for Pain, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Mild soreness of arm) and PAIN IN EXTREMITY (Pain in arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included blood pressure medications.  Patient gave verbal consent for safety to Follow-up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Bedridden, Ear pain, Headache, Myalgia
Clinical narrative: Arm aches; Earache; Been in bed drinking fluids; Stomach Cramps; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm aches), EAR PAIN (Earache), BEDRIDDEN (Been in bed drinking fluids), ABDOMINAL PAIN UPPER (Stomach Cramps) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm aches), EAR PAIN (Earache), BEDRIDDEN (Been in bed drinking fluids), ABDOMINAL PAIN UPPER (Stomach Cramps), HEADACHE (Headache) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm aches), EAR PAIN (Earache), BEDRIDDEN (Been in bed drinking fluids), ABDOMINAL PAIN UPPER (Stomach Cramps), HEADACHE (Headache) and MYALGIA (Body aches) outcome was unknown.            Concomitant medications include blood pressure medications.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.  Patient gave consent for safety to Follow-up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm aches; Earache; Been in bed drinking fluids; Stomach Cramps; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm aches), EAR PAIN (Earache), BEDRIDDEN (Been in bed drinking fluids), ABDOMINAL PAIN UPPER (Stomach Cramps) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm aches), EAR PAIN (Earache), BEDRIDDEN (Been in bed drinking fluids), ABDOMINAL PAIN UPPER (Stomach Cramps), HEADACHE (Headache) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm aches), EAR PAIN (Earache), BEDRIDDEN (Been in bed drinking fluids), ABDOMINAL PAIN UPPER (Stomach Cramps), HEADACHE (Headache) and MYALGIA (Body aches) outcome was unknown.            Concomitant medications include blood pressure medications.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.  Patient gave consent for safety to Follow-up.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site pain
Clinical narrative: Neck swollen on left side; Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Neck swollen on left side) and VACCINATION SITE PAIN (Sore left arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced SWELLING (Neck swollen on left side) and VACCINATION SITE PAIN (Sore left arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SWELLING (Neck swollen on left side) and VACCINATION SITE PAIN (Sore left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flat affect, Gait disturbance, Malaise, Panic attack
Clinical narrative: dizzy; ell like she was going to pass out; felt like a panic attack; felt very sleepy; lost her autonomy; She couldn't walk or control her sphincters (she peed all over her); This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), MALAISE (ell like she was going to pass out), PANIC ATTACK (felt like a panic attack), SOMNOLENCE (felt very sleepy) and FLAT AFFECT (lost her autonomy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (dizzy), MALAISE (ell like she was going to pass out), PANIC ATTACK (felt like a panic attack), SOMNOLENCE (felt very sleepy), FLAT AFFECT (lost her autonomy) and GAIT DISTURBANCE (She couldn't walk or control her sphincters (she peed all over her)). The patient was treated with DIAZEPAM at an unspecified dose and frequency. On 06-Mar-2021, PANIC ATTACK (felt like a panic attack) had resolved. On 07-Mar-2021, DIZZINESS (dizzy), MALAISE (ell like she was going to pass out), SOMNOLENCE (felt very sleepy), FLAT AFFECT (lost her autonomy) and GAIT DISTURBANCE (She couldn't walk or control her sphincters (she peed all over her)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: dizzy; ell like she was going to pass out; felt like a panic attack; felt very sleepy; lost her autonomy; She couldn't walk or control her sphincters (she peed all over her); This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), MALAISE (ell like she was going to pass out), PANIC ATTACK (felt like a panic attack), SOMNOLENCE (felt very sleepy) and FLAT AFFECT (lost her autonomy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (dizzy), MALAISE (ell like she was going to pass out), PANIC ATTACK (felt like a panic attack), SOMNOLENCE (felt very sleepy), FLAT AFFECT (lost her autonomy) and GAIT DISTURBANCE (She couldn't walk or control her sphincters (she peed all over her)). The patient was treated with DIAZEPAM at an unspecified dose and frequency. On 06-Mar-2021, PANIC ATTACK (felt like a panic attack) had resolved. On 07-Mar-2021, DIZZINESS (dizzy), MALAISE (ell like she was going to pass out), SOMNOLENCE (felt very sleepy), FLAT AFFECT (lost her autonomy) and GAIT DISTURBANCE (She couldn't walk or control her sphincters (she peed all over her)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site nodule, Pain in extremity
Clinical narrative: Sore arm day after 2nd shot; Red knot on arm day after 2nd shot; Red knot on arm day after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm day after 2nd shot), ERYTHEMA (Red knot on arm day after 2nd shot) and INJECTION SITE NODULE (Red knot on arm day after 2nd shot) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002a21a and 030l2la) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, METOPROLOL, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HYDROCHLOROTHIAZIDE), PREDNISONE, ACETYLSALICYLIC ACID (BABY ASPIRIN), SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), GABAPENTIN and PARACETAMOL (TYLENOL) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm day after 2nd shot). 06-Mar-2021, the patient experienced ERYTHEMA (Red knot on arm day after 2nd shot) and INJECTION SITE NODULE (Red knot on arm day after 2nd shot). At the time of the report, PAIN IN EXTREMITY (Sore arm day after 2nd shot), ERYTHEMA (Red knot on arm day after 2nd shot) and INJECTION SITE NODULE (Red knot on arm day after 2nd shot) outcome was unknown.            Treatment medication include Tylenol twice per day and noticed arm pain was more when the Tylenol started wearing off.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.   Reporter did not allow further contact
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hot flush, Hyperhidrosis, Myalgia, Pain
Clinical narrative: Felt like a truck ran over her; Was very sore and achy all over; Severe hot flashes; sweating all over body; Weak; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Felt like a truck ran over her), MYALGIA (Was very sore and achy all over), HOT FLUSH (Severe hot flashes), HYPERHIDROSIS (sweating all over body) and ASTHENIA (Weak) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation. Concomitant products included RIVAROXABAN (XARELTO) for Anticoagulant therapy, FUROSEMIDE for Fluid and electrolyte imbalance, ATENOLOL for Heart rate.    On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PAIN (Felt like a truck ran over her), MYALGIA (Was very sore and achy all over), HOT FLUSH (Severe hot flashes), HYPERHIDROSIS (sweating all over body) and ASTHENIA (Weak). On 07-Feb-2021, PAIN (Felt like a truck ran over her), MYALGIA (Was very sore and achy all over), HOT FLUSH (Severe hot flashes) and HYPERHIDROSIS (sweating all over body) had resolved and ASTHENIA (Weak) was resolving. Not Provided          treatment to the events not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-008873.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: additional information received patient demographic details, patient historical condition,  concomitant medications, outcome if the events are updated from recovering to recovered .
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 07-Mar-2021, PAIN IN EXTREMITY (Arm soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pyrexia
Clinical narrative: Did not feel well over the weekend; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel well over the weekend), PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Did not feel well over the weekend), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, MALAISE (Did not feel well over the weekend), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided  by the reporter.  Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: redness at injection site; swelling at injection site; achiness at injection site; fatigue; itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (achiness at injection site) and FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included DOXYCYCLINE and PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site). On 06-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (achiness at injection site) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (achiness at injection site) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.  Patient gave consent to safety for Follow-up.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Really hot to the touch; The injection site itchy; The injection site is red; The injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Really hot to the touch), VACCINATION SITE PRURITUS (The injection site itchy), VACCINATION SITE ERYTHEMA (The injection site is red) and VACCINATION SITE SWELLING (The injection site is swollen) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Really hot to the touch), VACCINATION SITE PRURITUS (The injection site itchy), VACCINATION SITE ERYTHEMA (The injection site is red) and VACCINATION SITE SWELLING (The injection site is swollen). At the time of the report, VACCINATION SITE WARMTH (Really hot to the touch), VACCINATION SITE PRURITUS (The injection site itchy), VACCINATION SITE ERYTHEMA (The injection site is red) and VACCINATION SITE SWELLING (The injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash macular, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Bumpy at the injection site, down to her elbow and left side of her breast; Blotches at the injection site, down to her elbow and left side of her breast; Itchy at the injection site, down to her elbow and left side of her breast; Soreness; Red at the injection site, down to her elbow and left side of her breast; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MASS (Bumpy at the injection site, down to her elbow and left side of her breast), RASH MACULAR (Blotches at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PRURITUS (Itchy at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PAIN (Soreness) and VACCINATION SITE ERYTHEMA (Red at the injection site, down to her elbow and left side of her breast) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Bumpy at the injection site, down to her elbow and left side of her breast), RASH MACULAR (Blotches at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PRURITUS (Itchy at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PAIN (Soreness), VACCINATION SITE ERYTHEMA (Red at the injection site, down to her elbow and left side of her breast) and HEADACHE (Headache). At the time of the report, VACCINATION SITE MASS (Bumpy at the injection site, down to her elbow and left side of her breast), RASH MACULAR (Blotches at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PRURITUS (Itchy at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PAIN (Soreness), VACCINATION SITE ERYTHEMA (Red at the injection site, down to her elbow and left side of her breast) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication information was reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Bumpy at the injection site, down to her elbow and left side of her breast; Blotches at the injection site, down to her elbow and left side of her breast; Itchy at the injection site, down to her elbow and left side of her breast; Soreness; Red at the injection site, down to her elbow and left side of her breast; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MASS (Bumpy at the injection site, down to her elbow and left side of her breast), RASH MACULAR (Blotches at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PRURITUS (Itchy at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PAIN (Soreness) and VACCINATION SITE ERYTHEMA (Red at the injection site, down to her elbow and left side of her breast) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Bumpy at the injection site, down to her elbow and left side of her breast), RASH MACULAR (Blotches at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PRURITUS (Itchy at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PAIN (Soreness), VACCINATION SITE ERYTHEMA (Red at the injection site, down to her elbow and left side of her breast) and HEADACHE (Headache). At the time of the report, VACCINATION SITE MASS (Bumpy at the injection site, down to her elbow and left side of her breast), RASH MACULAR (Blotches at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PRURITUS (Itchy at the injection site, down to her elbow and left side of her breast), VACCINATION SITE PAIN (Soreness), VACCINATION SITE ERYTHEMA (Red at the injection site, down to her elbow and left side of her breast) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site lymphadenopathy
Clinical narrative: swelling of a lymph node in the same arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (swelling of a lymph node in the same arm of the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swelling of a lymph node in the same arm of the injection). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swelling of a lymph node in the same arm of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information were not provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Heart rate, Hypertension, Illness, Memory impairment
Clinical narrative: blood pressure was high; vaccine effected memory; woke up sick again; body pain/muscle pain; chills; heart palpitation; pain in throat; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure was high), MEMORY IMPAIRMENT (vaccine effected memory), PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat) and ILLNESS (woke up sick again) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Athletic asthma).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat), MYALGIA (body pain/muscle pain) and CHILLS (chills). On 07-Mar-2021, the patient experienced ILLNESS (woke up sick again). On an unknown date, the patient experienced HYPERTENSION (blood pressure was high) and MEMORY IMPAIRMENT (vaccine effected memory). At the time of the report, HYPERTENSION (blood pressure was high), MEMORY IMPAIRMENT (vaccine effected memory), PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat), ILLNESS (woke up sick again), MYALGIA (body pain/muscle pain) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Heart rate: abnormal (abnormal) abnormal..         No concomitant drugs were reported. No treatment information was reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Palpitations
Clinical narrative: blood pressure was high; vaccine effected memory; woke up sick again; body pain/muscle pain; chills; heart palpitation; pain in throat; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure was high), MEMORY IMPAIRMENT (vaccine effected memory), PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat) and ILLNESS (woke up sick again) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Athletic asthma).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat), MYALGIA (body pain/muscle pain) and CHILLS (chills). On 07-Mar-2021, the patient experienced ILLNESS (woke up sick again). On an unknown date, the patient experienced HYPERTENSION (blood pressure was high) and MEMORY IMPAIRMENT (vaccine effected memory). At the time of the report, HYPERTENSION (blood pressure was high), MEMORY IMPAIRMENT (vaccine effected memory), PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat), ILLNESS (woke up sick again), MYALGIA (body pain/muscle pain) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Heart rate: abnormal (abnormal) abnormal..         No concomitant drugs were reported. No treatment information was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, SARS-CoV-2 test
Clinical narrative: Loss of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced AGEUSIA (Loss of taste). At the time of the report, AGEUSIA (Loss of taste) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported Treatment medications was not provided
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: neck pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 038K20A) for COVID-19 vaccination.     The patient's past medical history included Angina pectoris since an unknown date. Concomitant products included GLYCERYL TRINITRATE (NITROGLYCERIN TRANSDERMAL SYSTEM) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced NECK PAIN (neck pain). At the time of the report, NECK PAIN (neck pain) outcome was unknown. Not Provided          Treatment information was unknown   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up received on 03-MAY-2021, contains no new information.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Hyperhidrosis, Lacrimation increased, Nasal congestion
Clinical narrative: she developed like a cold; teary eyes; congestion; chills; checked temperature and it was 90; body aches; woke up in the middle night all sweaty; her body was cold; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), HYPERHIDROSIS (woke up in the middle night all sweaty), PERIPHERAL COLDNESS (her body was cold), NASOPHARYNGITIS (she developed like a cold) and LACRIMATION INCREASED (teary eyes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN and PRAVASTATIN for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (body aches), HYPERHIDROSIS (woke up in the middle night all sweaty), PERIPHERAL COLDNESS (her body was cold), BODY TEMPERATURE (checked temperature and it was 90) and CHILLS (chills). On 06-Mar-2021, the patient experienced NASOPHARYNGITIS (she developed like a cold), LACRIMATION INCREASED (teary eyes) and NASAL CONGESTION (congestion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-Mar-2021, PAIN (body aches), HYPERHIDROSIS (woke up in the middle night all sweaty), PERIPHERAL COLDNESS (her body was cold), NASOPHARYNGITIS (she developed like a cold), LACRIMATION INCREASED (teary eyes) and NASAL CONGESTION (congestion) had resolved. At the time of the report, BODY TEMPERATURE (checked temperature and it was 90) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Follow-up received on 9-mar-2021 which include Events Chills and checked Temperature and it was 90  and the Outcome of event was unknown .
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain, Peripheral coldness
Clinical narrative: she developed like a cold; teary eyes; congestion; chills; checked temperature and it was 90; body aches; woke up in the middle night all sweaty; her body was cold; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), HYPERHIDROSIS (woke up in the middle night all sweaty), PERIPHERAL COLDNESS (her body was cold), NASOPHARYNGITIS (she developed like a cold) and LACRIMATION INCREASED (teary eyes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN and PRAVASTATIN for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (body aches), HYPERHIDROSIS (woke up in the middle night all sweaty), PERIPHERAL COLDNESS (her body was cold), BODY TEMPERATURE (checked temperature and it was 90) and CHILLS (chills). On 06-Mar-2021, the patient experienced NASOPHARYNGITIS (she developed like a cold), LACRIMATION INCREASED (teary eyes) and NASAL CONGESTION (congestion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-Mar-2021, PAIN (body aches), HYPERHIDROSIS (woke up in the middle night all sweaty), PERIPHERAL COLDNESS (her body was cold), NASOPHARYNGITIS (she developed like a cold), LACRIMATION INCREASED (teary eyes) and NASAL CONGESTION (congestion) had resolved. At the time of the report, BODY TEMPERATURE (checked temperature and it was 90) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Follow-up received on 9-mar-2021 which include Events Chills and checked Temperature and it was 90  and the Outcome of event was unknown .
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site inflammation, Limb discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: swollen - left arm - it is like a square; red - left arm - it is like a square; hard - left arm- it is like a square; hot - left arm - it is like a square; raised like a hive - left arm - it is like a square; inflammation - left arm; soreness - left arm, arm hurt for a couple of days then went away - left arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen - left arm - it is like a square), ERYTHEMA (red - left arm - it is like a square), INJECTION SITE INFLAMMATION (inflammation - left arm), PAIN IN EXTREMITY (soreness - left arm, arm hurt for a couple of days then went away - left arm) and LIMB DISCOMFORT (hard - left arm- it is like a square) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced INJECTION SITE INFLAMMATION (inflammation - left arm) and PAIN IN EXTREMITY (soreness - left arm, arm hurt for a couple of days then went away - left arm). On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (swollen - left arm - it is like a square), ERYTHEMA (red - left arm - it is like a square), LIMB DISCOMFORT (hard - left arm- it is like a square), VACCINATION SITE WARMTH (hot - left arm - it is like a square) and URTICARIA (raised like a hive - left arm - it is like a square). At the time of the report, PERIPHERAL SWELLING (swollen - left arm - it is like a square), ERYTHEMA (red - left arm - it is like a square), INJECTION SITE INFLAMMATION (inflammation - left arm), PAIN IN EXTREMITY (soreness - left arm, arm hurt for a couple of days then went away - left arm), LIMB DISCOMFORT (hard - left arm- it is like a square), VACCINATION SITE WARMTH (hot - left arm - it is like a square) and URTICARIA (raised like a hive - left arm - it is like a square) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site warmth
Clinical narrative: swollen - left arm - it is like a square; red - left arm - it is like a square; hard - left arm- it is like a square; hot - left arm - it is like a square; raised like a hive - left arm - it is like a square; inflammation - left arm; soreness - left arm, arm hurt for a couple of days then went away - left arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen - left arm - it is like a square), ERYTHEMA (red - left arm - it is like a square), INJECTION SITE INFLAMMATION (inflammation - left arm), PAIN IN EXTREMITY (soreness - left arm, arm hurt for a couple of days then went away - left arm) and LIMB DISCOMFORT (hard - left arm- it is like a square) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced INJECTION SITE INFLAMMATION (inflammation - left arm) and PAIN IN EXTREMITY (soreness - left arm, arm hurt for a couple of days then went away - left arm). On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (swollen - left arm - it is like a square), ERYTHEMA (red - left arm - it is like a square), LIMB DISCOMFORT (hard - left arm- it is like a square), VACCINATION SITE WARMTH (hot - left arm - it is like a square) and URTICARIA (raised like a hive - left arm - it is like a square). At the time of the report, PERIPHERAL SWELLING (swollen - left arm - it is like a square), ERYTHEMA (red - left arm - it is like a square), INJECTION SITE INFLAMMATION (inflammation - left arm), PAIN IN EXTREMITY (soreness - left arm, arm hurt for a couple of days then went away - left arm), LIMB DISCOMFORT (hard - left arm- it is like a square), VACCINATION SITE WARMTH (hot - left arm - it is like a square) and URTICARIA (raised like a hive - left arm - it is like a square) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dysstasia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: legs gave out, he couldn't get up/legs still hurt. Little sore; difficult to stand up; bit dizzy; nauseous; fever/low fever but it keeps going down; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (legs gave out, he couldn't get up/legs still hurt. Little sore), DYSSTASIA (difficult to stand up), DIZZINESS (bit dizzy), NAUSEA (nauseous) and PYREXIA (fever/low fever but it keeps going down) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (legs gave out, he couldn't get up/legs still hurt. Little sore), DYSSTASIA (difficult to stand up), DIZZINESS (bit dizzy), NAUSEA (nauseous) and PYREXIA (fever/low fever but it keeps going down). At the time of the report, PAIN IN EXTREMITY (legs gave out, he couldn't get up/legs still hurt. Little sore), DYSSTASIA (difficult to stand up), DIZZINESS (bit dizzy), NAUSEA (nauseous) and PYREXIA (fever/low fever but it keeps going down) outcome was unknown.            Concomitant meds: a lot medications . Tx: nausea meds.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Circular Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Circular Rash) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included MEDROXYPROGESTERONE ACETATE (DEPO-PROVERA), FAMOTIDINE (PEPCID AC) and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RASH (Circular Rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Prophylaxis, at an unspecified dose and frequency. At the time of the report, RASH (Circular Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient was given steroid for treatment. Patient also took Benadryl on her own for treatment.